Literature DB >> 20564043

Cyclic peptides as potential therapeutic agents for skin disorders.

Sarika Namjoshi1, Heather A E Benson.   

Abstract

There is an increasing understanding of the role of peptides in normal skin function and skin disease. With this knowledge, there is significant interest in the application of peptides as therapeutics in skin disease or as cosmeceuticals to enhance skin appearance. In particular, antimicrobial peptides and those involved in inflammatory processes provide options for the development of new therapeutic directions in chronic skin conditions such as psoriasis and dermatitis. To exploit their potential, it is essential that these peptides are delivered to their site of action in active form and in sufficient quantity to provide the desired effect. Many polymers permeate the skin poorly and are vulnerable to enzymatic degradation. Synthesis of cyclic peptide derivatives can substantially alter the physicochemical characteristics of the peptide with the potential to improve its skin permeation. In addition, cyclization can stabilize the peptide structure and thereby increase its stability. This review describes the role of cyclic peptides in the skin, examples of current cyclic peptide therapeutic products, and the potential for cyclic peptides as dermatological therapeutics and cosmeceuticals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564043     DOI: 10.1002/bip.21476

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  8 in total

1.  Biologically relevant conformational features of linear and cyclic proteolipid protein (PLP) peptide analogues obtained by high-resolution nuclear magnetic resonance and molecular dynamics.

Authors:  Golfo G Kordopati; Haralambos Tzoupis; Anastassios N Troganis; Gerasimos M Tsivgoulis; Simona Golic Grdadolnik; Carmen Simal; Theodore V Tselios
Journal:  J Comput Aided Mol Des       Date:  2017-07-29       Impact factor: 3.686

2.  Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.

Authors:  Deepesh Nagarajan; Tushar Nagarajan; Natasha Roy; Omkar Kulkarni; Sathyabaarathi Ravichandran; Madhulika Mishra; Dipshikha Chakravortty; Nagasuma Chandra
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

3.  The two-step biosynthesis of cyclic peptides from linear precursors in a member of the plant family Caryophyllaceae involves cyclization by a serine protease-like enzyme.

Authors:  Carla J S Barber; Pareshkumar T Pujara; Darwin W Reed; Shiela Chiwocha; Haixia Zhang; Patrick S Covello
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

4.  Oxidation of the Cyanobactin Precursor Peptide Is Independent of the Leader Peptide and Operates in a Defined Order.

Authors:  Sisi Gao; Ying Ge; Andrew F Bent; Ulrich Schwarz-Linek; James H Naismith
Journal:  Biochemistry       Date:  2018-09-28       Impact factor: 3.162

Review 5.  YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function.

Authors:  Brandon J Burkhart; Christopher J Schwalen; Greg Mann; James H Naismith; Douglas A Mitchell
Journal:  Chem Rev       Date:  2017-03-03       Impact factor: 60.622

6.  From design to screening: a new antimicrobial peptide discovery pipeline.

Authors:  Saadet Albayrak Guralp; Yusuf E Murgha; Jean-Marie Rouillard; Erdogan Gulari
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

7.  Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with Diclofenac.

Authors:  Yousuf Mohammed; Meritxell Teixidó; Sarika Namjoshi; Ernest Giralt; Heather Benson
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

Review 8.  Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds.

Authors:  Anja Pfalzgraff; Klaus Brandenburg; Günther Weindl
Journal:  Front Pharmacol       Date:  2018-03-28       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.